Company profile
PreveCeutical Medical Inc.
OTC: PRVCF · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH 22DQ —GM —SS 37
v0.1 · 35/100 weight · pillars only
↑ disclosure history, market scale · ↓ balance-sheet leverage, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.1M
Employees
7
as of 2026-08-23
Market cap
$8.7M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$1.1M-1.6M CAD2025
Operating income-$2.4M-3.4M CAD2025
Total assets$1.1M1.4M CAD2025
Liabilities$5.6M7.7M CAD2025
Equity-$4.6M-6.2M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is PreveCeutical Medical Inc.’s revenue?
PreveCeutical Medical Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Theriva Biologics, Inc.39DLunai Bioworks Inc.20DGT Biopharma, Inc.32DRevive Therapeutics Ltd.——Unidoc Health Corp.——Vynleads, Inc.21DKey facts
CEOStephen Van Deventer
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeOTC: PRVCF
Employees7
IPO date2017-08-21
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.